San Diego, CANCT07771465Now EnrollingIRB Ready

Symptomatic Genetic Dilated Cardiomyopathy (DCM) Clinical Trial in San Diego, CA

Access cutting-edge symptomatic genetic dilated cardiomyopathy (dcm) treatment through this phase 3 clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.

Sponsored by Kardigan, Inc.

Quick Self-Assessment

See if you qualify for this San Diego location

Preparing your pre-screening questions…

Expert Care in San Diego

Access symptomatic genetic dilated cardiomyopathy (dcm) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related symptomatic genetic dilated cardiomyopathy (dcm) treatment provided free

Apply for This San Diego Location

Check if you qualify for this symptomatic genetic dilated cardiomyopathy (dcm) clinical trial in San Diego, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Diego

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Diego site if eligible
  4. 4Begin participation

About This Symptomatic Genetic Dilated Cardiomyopathy (DCM) Study in San Diego

Danicamtiv is an investigational medication, which means it is still being studied and has not been approved. The purpose of this study is to learn how well danicamtiv works, how safe it is, how well people can take it when used in patients with genetic or familial dilated cardiomyopathy (DCM). There are currently no approved medicines made specifically to treat genetic or familial DCM.

Sponsor: Kardigan, Inc.

Who Can Participate

Inclusion Criteria

Completed 24 weeks of blinded study treatment (corresponding to the Week 26 Visit in DAN-301) and planned assessments in Part 1 or Part 2 of the DAN-301 study.
If sexually active, must use a highly effective birth control method from the Screening Visit through 3 months after the last dose.
Is able to understand and comply with the study procedures, understand the risks involved in the study, and provide written informed consent according to local and institutional guidelines before the first study-specific procedure.

Exclusion Criteria

Acute coronary syndrome or hemodynamically significant epicardial coronary disease, or coronary revascularization (percutaneous coronary intervention \[PCI\] or coronary artery bypass graft \[CABG\]) performed within 90 days of DAN-302 Screening Visit.
Recent (\<90 days) hospitalization for heart failure (HF) or use of IV diuretic.
Other recent (\<90 days) cardiovascular events (e.g., cerebrovascular accident).
Hospitalization for sepsis or other systemic infections within 30 days of Screening. A systemic infection includes suspected or confirmed infection associated with fever, hemodynamic instability, bacteremia, or organ dysfunction typically requires urgent evaluation and/or acute care.
Any malignancy requiring treatment after enrollment in DAN-301 that could limit patient's survival.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Diego?

Yes, this clinical trial (NCT07771465) has an active research site in San Diego, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Symptomatic Genetic Dilated Cardiomyopathy (DCM) Treatment Options in San Diego, CA

If you're searching for symptomatic genetic dilated cardiomyopathy (dcm) treatment options in San Diego, CA, this clinical trial (NCT07771465) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Diego research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced symptomatic genetic dilated cardiomyopathy (dcm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all symptomatic genetic dilated cardiomyopathy (dcm) clinical trials near you to find additional studies recruiting in your area.

More Neuroendocrine Tumors Trials in San Diego, CA

See all neuroendocrine tumors clinical trials recruiting in San Diego — not just this study.

Browse Neuroendocrine Tumors Trials in San Diego →

Browse More Trials by Condition

Neuroendocrine Tumors TrialsCardiomyopathy TrialsEssential Tremor TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in San Diego?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Diego, CA